Construction of human-SCID chimeric mice.

Area of Science:

• Immunology
• Transplantation Biology
• Preclinical Research

Background:

• Traditional animal models like mice and nonhuman primates often fail to accurately replicate human physiological and pathophysiological processes.
• The limitations of existing models necessitate the development of more human-relevant preclinical systems.
• Severe combined immunodeficiency (SCID) mice offer a unique model due to their lack of a competent immune system, preventing rejection of foreign tissues.

Purpose of the Study:

• To detail the construction of SCID-human (SCID-hu) chimeric mice by xenografting human fetal hematolymphoid tissues.
• To provide protocols for establishing SCID-hu mouse models for enhanced preclinical therapeutic agent testing.
• To discuss the advantages, disadvantages, and applications of different SCID-hu mouse models.

Main Methods:

• Surgical implantation of human fetal thymus and liver under the kidney capsules of SCID mice (SCID-hu Thy/Liv model).
• Subcutaneous transplantation of human fetal bone marrow and thymus into SCID mice (SCID-hu Bm/Thy model).
• Protocols for analyzing human lymphocyte populations in peripheral blood and grafted organs of SCID-hu mice.

Main Results:

• Successful construction of SCID-hu chimeric mice engrafted with human fetal tissues.
• Demonstration of methods to analyze human immune cell populations within the SCID-hu model.
• Establishment of distinct SCID-hu models (Thy/Liv and Bm/Thy) for varied research applications.

Conclusions:

• SCID-hu mice provide a more accurate preclinical model for studying human immune system development and function.
• These xenograft models facilitate the testing of therapeutic agents in a humanized system.
• The described protocols offer valuable tools for immunological research and drug development.